Effects of transfection of human ribonuclease inhibitor gene on B16 melanoma cells and tumor metastasis

Progress in Biochemistry and Biophysics

Volumn 31, Issue 6, 2004, Pages 523-531

  Chen, Jun Xia ^a   Tian, Yu Xiang ^a   Fu, Pan Feng ^a   Xia, Jun ^b   Yan, Ping ^a   Cui, Xiu Yun ^a  

^a DALIAN MEDICAL UNIVERSITY   (China)

^b BENGBU MEDICAL COLLEGE   (China)

Author keywords

Angiogenesis; B16 cells; Metastasis; Ribonuclease inhibitor

Indexed keywords

COMPLEMENTARY DNA; ESTERASE INHIBITOR; RIBONUCLEASE; RIBONUCLEASE INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL; CANCER CELL; CANCER INHIBITION; CANCER INVASION; CELL ADHESION; CELL DIVISION; CELL MIGRATION; CELL PROLIFERATION; CELL STRUCTURE; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; CYTOPLASM; DENSITY; GENETIC TRANSFECTION; IMMUNOFLUORESCENCE; LUNG WEIGHT; MALE; MELANOMA CELL; METASTASIS; MOUSE; NONHUMAN; NUCLEOLUS; PHENOTYPE; POLYMERASE CHAIN REACTION; RETROVIRUS VECTOR; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALIA; UNIDENTIFIED RETROVIRUS;

EID: 3242786433     PISSN: 10003282     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Sharpiro R. Cytoplasmic ribonuclease inhibitor. In: Abelson JN, Simon MI, eds. Methods in Enzymology. San Diego: Academic Press, 2001. 611-628
2. Papageorgiou A C , Shapiro R, Acharya K R. Molecular recognition of human angiogenin by placental ribonuclease inhibitor. EMBO J, 1997, 16 (17): 5162-5177
3. Chen C Z, Shapiro R. Site-specific mutagenesis reveals differences in the structural bases for tight binding of RNase inhibitor to angiogenin and RNase A. Proc Natl Acad Sci USA, 1997, 94 (5): 1761-1766
4. Rybak S M, Sanovich E, Hollingshead M G, et al. "Vasocrine" formation of tumor cell- lined vascular spaces: implications for rational design of antiangiogenic therapies. Cancer Res, 2003, 63 (11): 2812-2819
5. Cuadros C, Dominguez A L, Frost GL, et al. Cooperative effect between immunotherapy and antiangiogenic therapy leads to effective tumor rejection in tolerant Her-2/neu mice. Cancer Res, 2003, 63 (18): 5895-5901
6. Estrada R B, Malet G, Revert F, et al. Antitumor effect of B16 melanoma cells genetically modified with the angiogensis inhibitor RNasin. Cancer Gene Ther, 2001, 8 (4): 278-284
7. Schneider R, Schneider-Scherzer E, Thurnher M, et al. The primary structure of human ribonuclease/angiogenin inhibitor (RI) discloses a novel highly diversified protein superfamily with a common repetitive module. EMBO J, 1988, 7 (13): 4151-4156
8. Hofsteenge J. Ribonuclease inhibitor. In: D' Alessio G, Riordan J F, eds. Ribonuclease: Structures and Functions. New York: Academic Press, 1997. 621-623
9. Polakowski I J, Lewis M K, Muthukkaruppan V R, et al. A ribonuclease inhibitor expression anti-angiogenic properties and leads to reduced tumor growth in mice. Am J Pathol, 1993, 143 (2): 507-517
10. Tian YX, Yu X P, Wang D M, et al. China oncology, 2001, 11 (6): 481-484
11. Wang N, Liu Z H, Ding F, et al. Acta Biochim Biophys Sin, 2003, 35 (1): 55-58
12. Menna P L, Skilton G S, Leskow F C, et al. Inhibition of aggressiveness of metastatic mouse mammary carcinoma cells by the β2-chimaerin GAP domain. Cancer Res, 2003, 63 (9): 2284-2291
13. Spurbeck W W, Ng C Y, Vanin E F, et al. Retroviral vector-producer cell-mediated in vivo gene transfer of TIMP-3 restricts angiogenesis and neuroblastoma growth in mice. Cancer Gene Ther, 2003, 10 (3): 161-167
14. Pepper M S. Lymphangiogenesis and tumor metastasis: Myth or reality?. Clin Cancer Res, 2001, 7 (3): 462-468
15. Hanford H A, Wong C A, Kassan H, et al. Angiostatin4. 5-mediated apoptosis of vascular endothelial cells. Cancer Res, 2003, 63 (14): 4275-4280
16. Lee F S, Shapiro R, Vallee B L. Tight-binding inhibition of angiogenin and ribonuclease A by placental ribonuclease inhibitor. Biochemistry, 1989, 28 (1): 225-230
17. Kobe B, Deisenhofer J. Crystal structure of porcine ribonuclease inhibitor, a protein with leucine-rich repeats. Nature, 1993, 366 (6457): 751-756
18. Shapiro R, Vallee B L. Human placental ribonuclease inhibitor abolishes both angiogenic and ribonucleolytic activities of angiogenin. Proc Natl Acad Sci USA, 1987, 84 (8): 2238-2241
19. Tian Y X, Zhang Y, Yu X P, et al. Tumor, 2002, 22 (5): 402 -404
20. Wang Z X, Zhang X, Fei Z, et al. Cancer, 2000, 19 (1): 51-53
21. Vanlyghem S A, Postenka C O, Chambers A F. Estrous cycle influences organ-specific metastasis of B16F10 melanoma cells. Cancer Res, 2003, 63 (16): 4763-4765
22. Weiss M, Hettmer S, Smish P, et al. Inhibition of melanoma tumor growth by a novel inhibitor of glucosylceramide synthase. Cancer Res, 2003, 63 (13): 3654-3658
23. Kurschat P, Mauch C. Mechanisms of metastasis. Clin Exp Dermatol, 2000, 25 (6): 482-489
24. Kamai T, Tsujii T, Arai K, et al. Significant association of Rho/ROCK pathway with invasion and metastasis of bladder cancer. Clin Cancer Res, 2003, 9 (7): 2632-2641